People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Flavocure Biotech, Inc. | — | Biotechnology | Seed | $1.3M | $748K | 2022 |
Ngeh Toyang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ngeh Toyang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Chapman | 1 | 5 |
| David Brooks | 1 | 3 |
| Thomas Lang | 1 | 2 |
| Douglas Liu | 1 | 1 |
| Swen Simms | 1 | 1 |
| David Traylor | 1 | 1 |
| Theresia Toyeng | 1 | 1 |
| Anthony Deasey | 1 | 1 |
| Saurabh Sewak | 1 | 1 |
| Justin Grant | 1 | 1 |
| Henry Lowe | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.